Wednesday, April 15, 2020

How 'hypermutated' malignant brain tumors escape chemotherapy and immunotherapy

An analysis of more than 10,000 gliomas and clinical outcomes found that glioma patients whose tumors were hypermutated actually had no significant benefit when treated with checkpoint blockers.

from Latest Science News -- ScienceDaily https://ift.tt/34Lwcy7
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

One tiny mutation may explain how bat viruses become human threats

Scientists found that one tiny genetic change can completely alter how a coronavirus behaves in different species. Comparing SARS-CoV-2 with...